Extremely Potent Orally Active Benzo[g]quinoline Analogue of the Dopaminergic Prodrug: 6-(N,N-Di-n-propyl)amino-3,4,5,6,7,8-hexahydro-2H-naphthalen-1-one-Reference-Cited by-同舟云学术

Extremely Potent Orally Active Benzo[g]quinoline Analogue of the Dopaminergic Prodrug: 6-(N,N-Di-n-propyl)amino-3,4,5,6,7,8-hexahydro-2H-naphthalen-1-one

Published:2006-01-25 Issue:4 Volume:49 Page:1494-1498
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Liu Danyang¹,Wikström Håkan V.¹,Dijkstra Durk¹,de Vries Jan B.¹,Venhuis Bastiaan J.¹

Affiliation:

1. Department of Medicinal Chemistry, University Centre for Pharmacy, University of Groningen, Antonius Deusinglaan 1, NL-9713 AV Groningen, The Netherlands

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm051111h

Reference27 articles.

1. Antiparkinsonian activity and dyskinesia risk of ropinirole and L-DOPA combination therapy in drug naive MPTP-lesioned common marmosets (Callithrix jacchus)

2. N-Alkyl derivatives oftrans-6,7-dihydroxy-1,2,3,4,4a,5,10,10b-octahyrobenzo[g]quinoline A congener of apomorphine lacking the non-oxygenated aromatic ring

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthetic Methods and Application of Phosphoester Prodrugs;PROG CHEM;2022

2. Dopamine agonists in treatment of Parkinson's disease: an overview;Diagnosis and Management in Parkinson's Disease;2020

3. Update 1 of: Recent Progress in Development of Dopamine Receptor Subtype-Selective Agents: Potential Therapeutics for Neurological and Psychiatric Disorders;Chemical Reviews;2013-05-08

4. Designing prodrugs for the treatment of Parkinson's disease;Expert Opinion on Drug Discovery;2012-04-12

5. Palladium-Catalyzed Coupling Reactions: Carbonylative Heck Reactions To Give Chalcones;Angewandte Chemie International Edition;2010-06-22